Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 69

1.

Drug resistance in malaria, tuberculosis, and HIV in South East Asia: biology, programme, and policy considerations.

Panda S, Swaminathan S, Hyder KA, Christophel EM, Pendse RN, Sreenivas AN, Laksono SJ, Srivastava R, Nair GB, Aditama TY, Singhasivanon P, Thapa AB, Sarkar SK.

BMJ. 2017 Sep 5;358:j3545. doi: 10.1136/bmj.j3545. No abstract available.

2.

Anti-malarial medicine quality field studies and surveys: a systematic review of screening technologies used and reporting of findings.

Lalani M, Kitutu FE, Clarke SE, Kaur H.

Malar J. 2017 May 15;16(1):197. doi: 10.1186/s12936-017-1852-6. Review.

3.

The malaria testing and treatment landscape in the southern Lao People's Democratic Republic (PDR).

ACTwatch Group, Phanalasy S.

Malar J. 2017 Apr 25;16(1):169. doi: 10.1186/s12936-017-1769-0.

4.

Local constraints to access appropriate malaria treatment in the context of parasite resistance in Cambodia: a qualitative study.

Verschuere J, Decroo T, Lim D, Kindermans JM, Nguon C, Huy R, Alkourdi Y, Peeters Grietens K, Gryseels C.

Malar J. 2017 Feb 17;16(1):81. doi: 10.1186/s12936-017-1732-0.

5.

Response to fever and utilization of standby emergency treatment (SBET) for malaria in travellers to Southeast Asia: a questionnaire-based cohort study.

Vinnemeier CD, Rothe C, Kreuels B, Addo MM, Vygen-Bonnet S, Cramer JP, Rolling T.

Malar J. 2017 Jan 25;16(1):44. doi: 10.1186/s12936-017-1678-2.

7.

Quality of Artemisinin-based Combination Therapy for malaria found in Ghanaian markets and public health implications of their use.

Tivura M, Asante I, van Wyk A, Gyaase S, Malik N, Mahama E, Hostetler DM, Fernandez FM, Asante KP, Kaur H, Owusu-Agyei S.

BMC Pharmacol Toxicol. 2016 Oct 28;17(1):48.

8.

Evidence of successful malaria case management policy implementation in Cambodia: results from national ACTwatch outlet surveys.

ACTwatch Group, Novotny J, Singh A, Dysoley L, Sovannaroth S, Rekol H.

Malar J. 2016 Apr 8;15:194. doi: 10.1186/s12936-016-1200-2.

9.

Quality Assessment of Artemether-Lumefantrine Samples and Artemether Injections Sold in the Cape Coast Metropolis.

Prah J, Ameyaw EO, Afoakwah R, Fiawoyife P, Oppong-Danquah E, Boampong JN.

J Trop Med. 2016;2016:8602619. doi: 10.1155/2016/8602619. Epub 2016 Feb 23.

10.

Degradation of Artemisinin-Based Combination Therapies Under Tropical Conditions.

Hall Z, Allan EL, van Schalkwyk DA, van Wyk A, Kaur H.

Am J Trop Med Hyg. 2016 May 4;94(5):993-1001. doi: 10.4269/ajtmh.15-0665. Epub 2016 Mar 7.

11.

An authenticity survey of herbal medicines from markets in China using DNA barcoding.

Han J, Pang X, Liao B, Yao H, Song J, Chen S.

Sci Rep. 2016 Jan 7;6:18723. doi: 10.1038/srep18723.

12.

An outbreak of artemisinin resistant falciparum malaria in Eastern Thailand.

Imwong M, Jindakhad T, Kunasol C, Sutawong K, Vejakama P, Dondorp AM.

Sci Rep. 2015 Nov 30;5:17412. doi: 10.1038/srep17412.

13.

Malaria Diagnosis Across the International Centers of Excellence for Malaria Research: Platforms, Performance, and Standardization.

Kobayashi T, Gamboa D, Ndiaye D, Cui L, Sutton PL, Vinetz JM.

Am J Trop Med Hyg. 2015 Sep;93(3 Suppl):99-109. doi: 10.4269/ajtmh.15-0004. Epub 2015 Aug 10. Review.

14.

Assessing the quality of anti-malarial drugs from Gabonese pharmacies using the MiniLab®: a field study.

Visser BJ, Meerveld-Gerrits J, Kroon D, Mougoula J, Vingerling R, Bache E, Boersma J, van Vugt M, Agnandji ST, Kaur H, Grobusch MP.

Malar J. 2015 Jul 15;14:273. doi: 10.1186/s12936-015-0795-z.

15.

Bioeconomic analysis of child-targeted subsidies for artemisinin combination therapies: a cost-effectiveness analysis.

Klein EY, Smith DL, Cohen JM, Laxminarayan R.

J R Soc Interface. 2015 Jun 6;12(107). pii: 20141356. doi: 10.1098/rsif.2014.1356.

16.

Quality of Artemisinin-Containing Antimalarials in Tanzania's Private Sector--Results from a Nationally Representative Outlet Survey.

ACT Consortium Drug Quality Project Team and the IMPACT2 Study Team.

Am J Trop Med Hyg. 2015 Jun;92(6 Suppl):75-86. doi: 10.4269/ajtmh.14-0544. Epub 2015 Apr 20.

17.

Quality of antimalarials at the epicenter of antimalarial drug resistance: results from an overt and mystery client survey in Cambodia.

Yeung S, Lawford HL, Tabernero P, Nguon C, van Wyk A, Malik N, DeSousa M, Rada O, Boravann M, Dwivedi P, Hostetler DM, Swamidoss I, Green MD, Fernandez FM, Kaur H.

Am J Trop Med Hyg. 2015 Jun;92(6 Suppl):39-50. doi: 10.4269/ajtmh.14-0391. Epub 2015 Apr 20.

18.

A Repeat Random Survey of the Prevalence of Falsified and Substandard Antimalarials in the Lao PDR: A Change for the Better.

Tabernero P, Mayxay M, Culzoni MJ, Dwivedi P, Swamidoss I, Allan EL, Khanthavong M, Phonlavong C, Vilayhong C, Yeuchaixiong S, Sichanh C, Sengaloundeth S, Kaur H, Fernández FM, Green MD, Newton PN.

Am J Trop Med Hyg. 2015 Jun;92(6 Suppl):95-104. doi: 10.4269/ajtmh.15-0057. Epub 2015 Apr 20.

19.

Rapid and specific drug quality testing assay for artemisinin and its derivatives using a luminescent reaction and novel microfluidic technology.

Ho NT, Desai D, Zaman MH.

Am J Trop Med Hyg. 2015 Jun;92(6 Suppl):24-30. doi: 10.4269/ajtmh.14-0392. Epub 2015 Apr 20.

20.

Substandard/counterfeit antimicrobial drugs.

Kelesidis T, Falagas ME.

Clin Microbiol Rev. 2015 Apr;28(2):443-64. doi: 10.1128/CMR.00072-14. Review.

Supplemental Content

Support Center